Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.!
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Dashatinib Intermediate
Dashatinib Is An Effective Dual Ablwt/Src Inhibitor With Ic50 Of 0.6 Nm/0.8 Nm And C-Kitwt/C-Kitd816V And Ic50 Of 79 Nm/37 Nm Respectively. It Is A Chemotherapeutic Drug For Chronic Myeloid Leukemia (Cml) And Acute Lymphoblastic Leukemia (All). Specifical
No data